- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/47 - One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
Patent holdings for IPC class C07D 239/47
Total number of patents in this class: 716
10-year publication summary
|
83
|
53
|
57
|
53
|
51
|
43
|
37
|
26
|
24
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ADAMA Makhteshim Ltd. | 506 |
39 |
| Bristol-myers Squibb Company | 4878 |
25 |
| Novartis AG | 10867 |
14 |
| Oxular Acquisitions Limited | 21 |
14 |
| Boehringer Ingelheim International GmbH | 4695 |
13 |
| Carnegie Mellon University | 1528 |
11 |
| Corteva Agriscience LLC | 2661 |
11 |
| Genentech, Inc. | 3975 |
8 |
| Celgene Quanticel Research, Inc. | 163 |
8 |
| Curza Global, LLC | 29 |
8 |
| Emergent BioDefense Operations Lansing LLC | 29 |
8 |
| Shionogi & Co., Ltd. | 860 |
8 |
| University of Utah Research Foundation | 1809 |
8 |
| Merck Patent GmbH | 5829 |
7 |
| Actelion Pharmaceuticals Ltd | 533 |
7 |
| Eli Lilly and Company | 3834 |
7 |
| Kowa Company, Ltd. | 1197 |
7 |
| Ono Pharmaceutical Co., Ltd. | 434 |
7 |
| AstraZeneca AB | 2917 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2558 |
6 |
| Other owners | 494 |